SCHEMBL10262126

SCHEMBL10262126

CCN(C)C(=O)n1c(=O)n(C)c2nc(C3CC3)ncc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN1 Q05586 3/20 0.36
▸ GRIN2B Q13224 3/20 0.36
▸ TSHR P16473 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ TAS2R14 Q9NYV8 2/20 0.34
▸ PKM P14618 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ RECQL P46063 2/20 0.33
▸ FOS P01100 1/20 0.33
▸ JUN P05412 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ GABRG2 P18507 1/20 0.32
▸ GABRB3 P28472 1/20 0.32
▸ GABRA5 P31644 1/20 0.32
▸ PDE3B Q13370 1/20 0.32
▸ PDE3A Q14432 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10006787 0.95 TAS2R14 (0.39) GRIN1GRIN2BTP53TAS2R14ALDH1A1
SCHEMBL10267698 0.82 TAS2R14 (0.41) GRIN1GRIN2BTAS2R14TSPO
SCHEMBL10006474 0.82 MEN1 (0.38) GRIN1GRIN2BNPC1
SCHEMBL10267641 0.81 GRIN1 (0.35) GRIN1GRIN2BTAS2R14HSD17B10TSPO
SCHEMBL12830371 0.81 TAS2R14 (0.34) GRIN1GRIN2BTAS2R14SMN1; SMN2TSPO
SCHEMBL10006847 0.80 MEN1 (0.35) GRIN1GRIN2BTAS2R14ALDH1A1NFKB1
SCHEMBL10007102 0.80 ALDH1A1 (0.36) GRIN1GRIN2BTSHRTP53TAS2R14
SCHEMBL10006463 0.78 MEN1 (0.36) TP53TAS2R14NPC1SMN1; SMN2PDE3B
SCHEMBL10006781 0.77 TSPO (0.40) PKMALDH1A1FOSJUNNFKB1
SCHEMBL10006848 0.76 TSPO (0.52) GRIN1GRIN2BTSHRTP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735406-B2 8-oxodihydropurine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-05-27 — — US disclosed
US-8735406-B2 8-oxodihydropurine derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2014-05-27 — — US disclosed
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-05 — — US disclosed
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172347-A1 8-OXODIHYDROPURINE DERIVATIVE FAAH, FAAH2, TPMT GRIN1 718/4885GRIN2B 635/4885TSHR 3750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback